Huaxin Sheng holds an M.D. degree. He graduated from the Nantong University School of Medicine, Nantong, China, in 1984 and completed residency training at the Hebei Medical University Hospital, Hebei, China, in 1992 and a fellowship at the Duke University Medical Center, Durham, NC, USA, in 1996. He joined the Department of Anesthesiology as a Faculty Member in 1999 and focused on studying the effects of anesthetic agents on ischemic brain injury, which is a potential surgical risk from cardiopulmonary bypass and other surgical procedures. He is an Associate Professor of anesthesiology and a Codirector of the Multidisciplinary Neuroprotection Laboratories at Duke University Medical Center, Durham, NC, USA. Currently, he is dedicated to translational research in the field of brain and spinal cord injuries and is leading several projects supported by the NIH and pharmaceutical companies. His major interest is to develop a new strategy to ameliorate the oxidative/nitrosative stress resulting from brain and spinal cord injuries, reducing tissue damage, and promoting neurologic and cognitive function recovery. He has published 70 peer-reviewed papers and filed three pending patents in treating neurological diseases, such as stroke, head trauma, spinal cord ischemia, cerebral arterial vasospasm, and neonatal hypoxia. He is also an active ad hoc reviewer for multiple journals (e.g., Anesthesia & Analgesia, Neurocritical Care, Journal of Neurotrauma, British Journal of Pharmacology, European Journal of Clinical Investigation, Journal of Signal Transduction, Neurobiology of Disease, and Critical Care and Medicine) and several funding agencies (e.g., MRC and CDMRP).
Biography Updated on 12 October 2013